Application 1044
Ostase immunoassay for the mass measurement of serum bone alkaline phosphatase
Application No | 1044 |
| Application Name | Ostase immunoassay for the mass measurement of serum bone alkaline phosphatase |
| Advisory Panel | Professor Syd Bell (Chair and MSAC member) Professor Jane Hall (MSAC member) Ms Rebecca James (MSAC member) Associate Professor Peter Ebeling (Endocrine Society of Australia ) Dr Helen Healy (Australian and New Zealand Society of Nephrology ) Clinical Associate Professor Michael J Hooper (Royal Australasian College of Physicians) Dr Graham Jones (Australian Association of Clinical Biochemist ) Dr David Malouf (Urological Society of Australasia) Dr Jitendra Parikh (Royal Australian College of General Practitioners ) Dr Samuel Vasikaran (Royal College of Pathologists of Australasia) |
| Date Received by MSAC Secretariat | 20 April 2001 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 21 May 2003 meeting. Since there is currently insufficient evidence pertaining to the effectiveness and cost-effectiveness of Ostase diagnostic laboratory tests (Tandem-R Ostase, Tandem-MP Ostase and Access Ostase) in the diganosis and monitoring of treatment in Paget's disease of bone, renal osteodystrophy, bone metastases of prostate cancer and osteoporosis, the MSAC recommended that public funding should not be supported at this time for these tests. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing 8 August 2003 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 03 April, 2009
